Full Text
PBI10 Cost Effectiveness Analysis for the Treatment of Psoriasis: The Use of Adalimumab Biosimilars

Abstract

Authors

T. Weber M. Bodin P. Pemberton-Ross P. Haines C. Bas B. Pieper H. Ebbers F. Sasso S. Keady

Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×